$CUTR
CUTERA INC Stock $cutr

$cutr Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000143774921011396 Filed on May 10, 2021

Income Statement

Concept	2021 Q1	2020 Q4	2020 Q1
Revenue	$49.67M	$49.94M	$32.24M
YoY Change	54.06%	-3.58%	-10.51%
Cost Of Revenue	$21.96M	$21.88M	$17.90M
YoY Change	22.65%	-4.9%	-4.35%
Gross Profit	$27.71M	$28.07M	$14.34M
YoY Change	93.29%	-2.51%	-17.18%
Gross Profit Margin	55.79%	56.2%	44.47%
Selling, General & Admin	$22.43M	$22.59M	$22.60M
YoY Change	-0.72%	-13.95%	4.47%
% of Gross Profit	80.96%	80.5%	157.61%
Research & Development	$4.112M	$4.029M	$3.870M
YoY Change	6.25%	-9.72%	4.43%
% of Gross Profit	14.84%	14.36%	26.99%
Depreciation & Amortization	$360.0K	$330.0K	$360.0K
YoY Change	0.0%	-10.81%	-12.41%
% of Gross Profit	1.3%	1.18%	2.51%
Operating Expenses	$26.55M	$26.62M	$26.47M
YoY Change	0.3%	-13.33%	4.46%
Operating Profit	$1.165M	$1.443M	-$12.13M
YoY Change	-109.61%	-174.81%	51.12%
Interest Expense	$243.0K	$10.00K	-$210.0K
YoY Change	-215.71%	-150.0%	162.5%
% of Operating Profit	20.86%	0.69%
Other Income/Expense, Net	-$1.266M	$7.000K	-$207.0K
YoY Change	511.59%	-135.0%	162.03%
Pretax Income	-$101.0K	$1.450M	-$12.34M
YoY Change	-99.18%	-174.4%	52.2%
Income Tax	$300.0K	-$738.0K	$78.00K
% Of Pretax Income		-50.9%
Net Earnings	-$359.0K	$2.188M	-$12.41M
YoY Change	-97.11%	-204.79%	51.02%
Net Earnings / Revenue	-0.72%	4.38%	-38.51%
Basic Earnings Per Share	-$0.02	$0.12	-$0.86
Diluted Earnings Per Share	-$0.02	$0.12	-$0.86
COMMON SHARES
Basic Shares Outstanding	17.77M shares	17.65M	14.43M
Diluted Shares Outstanding	17.77M shares	17.84M	14.43M

Balance Sheet

Concept	2021 Q1	2020 Q4	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$164.9M	$47.05M	$19.50M
YoY Change	745.64%	38.78%	-28.04%
Cash & Equivalents	$164.9M	$47.05M	$14.77M
Short-Term Investments		$0.00	$4.700M
Other Short-Term Assets	$10.30M	$8.800M	$4.800M
YoY Change	114.58%	57.14%	-2.04%
Inventory	$34.58M	$28.51M	$36.94M
Prepaid Expenses
Receivables	$24.15M	$21.96M	$15.66M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$234.0M	$106.3M	$76.95M
YoY Change	204.09%	11.84%	-1.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.373M	$2.299M	$2.687M
YoY Change	-11.69%	-18.39%	11.63%
Goodwill	$1.339M	$1.300M	$1.339M
YoY Change	0.0%	-2.91%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.853M	$5.080M	$5.901M
YoY Change	-17.76%	-20.76%	-0.99%
Total Long-Term Assets	$25.73M	$26.44M	$17.48M
YoY Change	47.23%	41.43%	-10.82%
TOTAL ASSETS
Total Short-Term Assets	$234.0M	$106.3M	$76.95M
Total Long-Term Assets	$25.73M	$26.44M	$17.48M
Total Assets	$259.7M	$132.7M	$94.43M
YoY Change	175.05%	16.7%	-3.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.031M	$6.684M	$14.60M
YoY Change	-65.55%	-47.31%	41.28%
Accrued Expenses	$41.33M	$32.30M	$23.66M
YoY Change	74.66%	6.56%	8.61%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.800M	$3.630M	$500.0K
YoY Change	1260.0%		-16.67%
Total Short-Term Liabilities	$66.12M	$54.36M	$52.42M
YoY Change	26.15%	-7.27%	11.77%
LONG-TERM LIABILITIES
Long-Term Debt	$134.9M	$3.800M	$400.0K
YoY Change	33625.0%	533.33%	0.0%
Other Long-Term Liabilities	$434.0K	$242.0K	$447.0K
YoY Change	-2.91%	-58.13%
Total Long-Term Liabilities	$434.0K	$242.0K	$447.0K
YoY Change	-2.91%	-58.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$66.12M	$54.36M	$52.42M
Total Long-Term Liabilities	$434.0K	$242.0K	$447.0K
Total Liabilities	$218.1M	$75.85M	$60.89M
YoY Change	258.17%	11.88%	4.57%
SHAREHOLDERS EQUITY
Retained Earnings	-$60.59M	-$60.24M	-$48.77M
YoY Change	24.24%	65.67%	51.32%
Common Stock	$102.2M	$117.1M	$82.31M
YoY Change	24.2%	42.2%	15.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$41.63M	$56.88M	$33.54M
YoY Change
Total Liabilities & Shareholders Equity	$259.7M	$132.7M	$94.43M
YoY Change	175.05%	16.7%	-3.0%

Cashflow Statement

Concept	2021 Q1	2020 Q4	2020 Q1
OPERATING ACTIVITIES
Net Income	-$359.0K	$2.188M	-$12.41M
YoY Change	-97.11%	-204.79%	51.02%
Depreciation, Depletion And Amortization	$360.0K	$330.0K	$360.0K
YoY Change	0.0%	-10.81%	-12.41%
Cash From Operating Activities	$1.253M	$4.470M	-$11.97M
YoY Change	-110.47%	12.59%	50.46%
INVESTING ACTIVITIES
Capital Expenditures	$101.0K	-$510.0K	$230.0K
YoY Change	-56.09%	8.51%	253.85%
Acquisitions
YoY Change
Other Investing Activities	$50.00K	$13.08M	$2.870M
YoY Change	-98.26%	-1257.52%	78.26%
Cash From Investing Activities	-$49.00K	$12.58M	$2.640M
YoY Change	-101.86%	-886.25%	70.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$116.7M	610.0K	-$2.216M
YoY Change	-5365.39%	-42.45%	352.24%
NET CHANGE
Cash From Operating Activities	$1.253M	4.470M	-$11.97M
Cash From Investing Activities	-$49.00K	12.58M	$2.640M
Cash From Financing Activities	$116.7M	610.0K	-$2.216M
Net Change In Cash	$117.9M	17.66M	-$11.54M
YoY Change	-1121.36%	414.87%	67.42%
FREE CASH FLOW
Cash From Operating Activities	$1.253M	$4.470M	-$11.97M
Capital Expenditures	$101.0K	-$510.0K	$230.0K
Free Cash Flow	$1.152M	$4.980M	-$12.20M
YoY Change	-109.45%	12.16%	52.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	61000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	61000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-359000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12353000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	396000	USD
CY2021Q1	cutr	Adjustments To Additional Paid In Capital Purchase Of Capped Call AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCall	-16134000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-999000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1846000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-359000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	41630000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	45942000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	200000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-2233000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1980000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-12414000	USD
CY2020Q4	us-gaap	Assets Assets	132733000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5031000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6684000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41329000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31079000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2351000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2260000	USD
CY2021Q1	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	1039000	USD
CY2020Q4	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	1216000	USD
CY2021Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10019000	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	9489000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	66121000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	54358000	USD
CY2021Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1718000	USD
CY2020Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1748000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15394000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4853000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5080000	USD
CY2021Q1	us-gaap	Assets Assets	259733000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15950000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	75853000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	18000	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	102206000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	117097000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60594000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60235000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	41630000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	49668000	USD
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17803274
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1611000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1598000	USD
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	4665000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17801926
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17801926
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17679232
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17679232
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	56880000	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-359000	USD
CY2020Q1	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	0	USD
CY2020Q4	us-gaap	Litigation Reserve LitigationReserve	0	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	243000	USD
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	164932000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47047000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24151000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21962000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	34578000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	28508000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10339000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8779000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	234000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	106296000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2373000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2299000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	598000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	643000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16570000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17076000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	1339000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1339000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	32239000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21958000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17903000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3870000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7365000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7806000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	26545000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	26465000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1165000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12129000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	52000	USD
CY2020Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	-0	USD
CY2021Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1023000	USD
CY2020Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	207000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1266000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-207000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-101000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12336000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	258000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	78000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-359000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-12414000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	17768000
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14433000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-359000	USD
CY2021Q1	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	6352000	USD
CY2020Q4	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	3630000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-12414000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	434000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	242000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-0	USD
CY2021Q1	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	851000	USD
CY2020Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	3555000	USD
CY2021Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	133585000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	218103000	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	18000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	56880000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	259733000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	132733000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	27710000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	14336000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15068000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14789000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-0	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4112000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-61000	USD
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	191000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.86
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	0	USD
CY2021Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	16134000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	61000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	33536000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-359000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-12414000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1846000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1980000	USD
CY2021Q1	cutr	Depreciation And Amortization Excluding Contract Acquisition Costs DepreciationAndAmortizationExcludingContractAcquisitionCosts	361000	USD
CY2020Q1	cutr	Depreciation And Amortization Excluding Contract Acquisition Costs DepreciationAndAmortizationExcludingContractAcquisitionCosts	360000	USD
CY2021Q1	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	545000	USD
CY2020Q1	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	717000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	52000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2021Q1	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	182000	USD
CY2020Q1	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	45000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	218000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	590000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	59000	USD
CY2020Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	USD
CY2021Q1	cutr	Change In Rightofuse Asset And Liability Due To Modification ChangeInRightofuseAssetAndLiabilityDueToModification	604000	USD
CY2020Q1	cutr	Change In Rightofuse Asset And Liability Due To Modification ChangeInRightofuseAssetAndLiabilityDueToModification	645000	USD
CY2021Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	USD
CY2020Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	35000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2407000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5306000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6021000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3020000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1560000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-807000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	500000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	207000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1653000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1919000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10199000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6567000	USD
CY2021Q1	cutr	Increase Decrease In Extended Product Warranty Accrual IncreaseDecreaseInExtendedProductWarrantyAccrual	-177000	USD
CY2020Q1	cutr	Increase Decrease In Extended Product Warranty Accrual IncreaseDecreaseInExtendedProductWarrantyAccrual	-234000	USD
CY2021Q1	cutr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-563000	USD
CY2020Q1	cutr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-645000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	500000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1253000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1253000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11966000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	101000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	230000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	52000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	6800000	USD
CY2021Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	USD
CY2020Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3930000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-49000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2640000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	117885000	USD
CY2020Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	-0	USD
CY2021Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	138250000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2234000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11542000	USD
CY2020Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4717000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	396000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	201000	USD
CY2020Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	999000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	115000	USD
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	183000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	116681000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2216000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47047000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	164932000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14774000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26316000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	25000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	123000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	452000	USD
CY2020Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	458000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	75000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	200000	USD
CY2021Q1	cutr	Capped Call Transactions Costs CappedCallTransactionsCosts	16100000	USD
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of Condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, implicit and incremental borrowing rates related to the Company’s leases, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, assumptions used in operating and sales-type lease classification, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	164932000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47047000	USD
CY2021Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2021Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	15335000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	14874000	USD
CY2021Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1359000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1030000	USD
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17884000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12604000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	34578000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	28508000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5803000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41329000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31079000	USD
CY2018	us-gaap	Extended Product Warranty Accrual Payments ExtendedProductWarrantyAccrualPayments	3200000	USD
CY2021Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	12558000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	12197000	USD
CY2021Q1	cutr	Accrued Sales And Marketing Costs Current AccruedSalesAndMarketingCostsCurrent	3134000	USD
CY2020Q4	cutr	Accrued Sales And Marketing Costs Current AccruedSalesAndMarketingCostsCurrent	2352000	USD
CY2021Q1	cutr	Accrued Inventory Current AccruedInventoryCurrent	7501000	USD
CY2020Q4	cutr	Accrued Inventory Current AccruedInventoryCurrent	2476000	USD
CY2021Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3351000	USD
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2908000	USD
CY2021Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6935000	USD
CY2020Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5343000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7850000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2908000	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4401000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1525000	USD
CY2020Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	860000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1082000	USD
CY2020Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1863000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3351000	USD
CY2020Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3398000	USD
CY2021Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	1000000.0	USD
CY2020Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	1800000	USD
CY2021Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1100000	USD
CY2020Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1900000	USD
CY2021Q1	us-gaap	Extended Product Warranty Accrual Payments ExtendedProductWarrantyAccrualPayments	200000	USD
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.85	pure
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	11700000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11237000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14222000	USD
CY2021Q1	cutr	Contract With Customer Liability Increase Advance Payments Received ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived	4929000	USD
CY2020Q1	cutr	Contract With Customer Liability Increase Advance Payments Received ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived	3571000	USD
CY2021Q1	cutr	Contract With Customer Liability Decrease From Revenue Deferred ContractWithCustomerLiabilityDecreaseFromRevenueDeferred	445000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11737000	USD
CY2020Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	12969000	USD
CY2021Q1	cutr	Costs For Extended Service Contracts CostsForExtendedServiceContracts	2000000.0	USD
CY2020Q1	cutr	Costs For Extended Service Contracts CostsForExtendedServiceContracts	2200000	USD
CY2020Q1	cutr	Contract With Customer Liability Decrease From Revenue Deferred ContractWithCustomerLiabilityDecreaseFromRevenueDeferred	592000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3984000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4232000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1085170
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	217007
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.35
CY2021Q1	cutr	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross	234227
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	24090
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	16.41
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2500
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	2500
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	39.30
CY2021Q1	cutr	Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod	58232
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	911675
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	259090
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.53
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1846000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1980000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-12414000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17768000
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14433000
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2020Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17768000
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14433000
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.86
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5119000
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1232000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	258000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	78000	USD
CY2021Q1	cutr	Lease Rightofuse Asset LeaseRightofuseAsset	16988000	USD
CY2020Q4	cutr	Lease Rightofuse Asset LeaseRightofuseAsset	17543000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	17745000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	18210000	USD
CY2021Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	418000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	370000	USD
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	434000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	241000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	852000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	611000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	127000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	149000	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	14000	USD
CY2020Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	19000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	878000	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	728000	USD
CY2021Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	14000	USD
CY2020Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	19000	USD
CY2021Q1	cutr	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	115000	USD
CY2020Q1	cutr	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	120000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	772000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	727000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2327000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y6M
CY2021Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y10M24D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047	pure
CY2021Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2021Q1	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	0	USD
CY2021Q1	cutr	Proceeds From Exercise Of Purchase Option Sales Type Lease ProceedsFromExerciseOfPurchaseOptionSalesTypeLease	100000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	100000	USD
CY2021Q1	us-gaap	Litigation Reserve LitigationReserve	400000	USD
CY2021Q1	us-gaap	Derivative Cap Price DerivativeCapPrice	45.5350
CY2021Q1	cutr	Derivative Cap Price Premium Over Stock Price Percent DerivativeCapPricePremiumOverStockPricePercent	0.75	pure
CY2021Q1	us-gaap	Share Price SharePrice	26.02
CY2021Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	16100000	USD
CY2021Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	4700000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	52000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	52000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	49668000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	32239000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	49668000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	32239000	USD

Files In Submission

Name	View Source	Status
0001437749-21-011396-index-headers.html	Edgar Link	pending
0001437749-21-011396-index.html	Edgar Link	pending
0001437749-21-011396.txt	Edgar Link	pending
0001437749-21-011396-xbrl.zip	Edgar Link	pending
cutr-20210331.xsd	Edgar Link	pending
cutr-20210331_cal.xml	Edgar Link	unprocessable
cutr-20210331_def.xml	Edgar Link	unprocessable
cutr-20210331_lab.xml	Edgar Link	unprocessable
cutr-20210331_pre.xml	Edgar Link	unprocessable
cutr20210331_10q.htm	Edgar Link	pending
cutr20210331_10q_htm.xml	Edgar Link	completed
ex_243527.htm	Edgar Link	pending
ex_243538.htm	Edgar Link	pending
ex_243539.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CUTR
CUTERA INC Stock $cutr

2021 Q1 Form 10-Q Financial Statement

#000143774921011396 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUTR CUTERA INC Stock $cutr

2021 Q1 Form 10-Q Financial Statement

#000143774921011396 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUTR
CUTERA INC Stock $cutr